Qube Research & Technologies (QRT)’s Gilead Sciences GILD Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.13M	Sell	65,500 -5,900	-8%	-$826K	0.01%	1328
2025 Q4	$8.76M	Buy	71,400 +12,300	+21%	+$1.49M	0.01%	1431
2025 Q3	$6.56M	Sell	59,100 -44,200	-43%	-$5.02M	0.01%	1588
2025 Q2	$11.5M	Buy	103,300 +16,700	+19%	+$1.78M	0.01%	1211
2025 Q1	$9.7M	Buy	86,600 +72,100	+497%	+$7.44M	0.01%	1159
2024 Q4	$1.34M	Sell	14,500 -10,800	-43%	-$972K	﹤0.01%	2046
2024 Q3	$2.12M	Sell	25,300 -29,500	-54%	-$2.25M	﹤0.01%	1742
2024 Q2	$3.76M	Buy	+54,800	New	+$3.66M	0.01%	1390
2024 Q1	–	Sell	-12,400	Closed	-$1M	–	4618
2023 Q4	$1M	Sell	12,400 -29,700	-71%	-$2.31M	﹤0.01%	1927
2023 Q3	$3.15M	Buy	42,100 +41,800	+13,933%	+$3.22M	0.01%	1152
2023 Q2	$23.1K	Buy	+300	New	+$23.9K	﹤0.01%	2150

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Qube Research & Technologies (QRT)'s GILD Position: Q1 2026 in Review

Qube Research & Technologies (QRT) reduced its Gilead Sciences (GILD) stake by 95% in Q1 2026, selling an estimated $340M and leaving 121,052 shares worth $16.9M. The position accounts for 0.02% of the portfolio, ranked #970.

Qube Research & Technologies (QRT) first reported a position in GILD in Q1 2018 and has held it in 28 quarters since. The position peaked at $536M in Q3 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Qube Research & Technologies (QRT) held 121,052 shares of Gilead Sciences worth $16.9M as of Q1 2026.
Qube Research & Technologies (QRT) sold 2,425,986 Gilead Sciences shares in Q1 2026, an estimated $340M.
Gilead Sciences made up 0.02% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #970 holding.
Qube Research & Technologies (QRT) first reported a position in Gilead Sciences in Q1 2018 and has held it in 28 quarters since.
Qube Research & Technologies (QRT)'s Gilead Sciences position peaked at $536M in Q3 2025.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.